C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Oct 14

PMID 36231090

Authors

Ru-Huei Fu

Chia-Wen Tsai

Shao-Chih Chiu

Shih-Ping Liu

Yu-Ting Chiang

Yun-Hua Kuo

Woei-Cherng Shyu

Shinn-Zong Lin

Affiliations

Soon will be listed here.

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal disease in which motor neurons gradually degenerate. The mutation of the gene is the main genetic cause of ALS (C9-ALS). One of its specific pathological features is the production of proline-arginine (PR) dipeptide repeat protein (DPR). In this study, we developed a PR-DPR (PR)-expressing human HMC3 microglial cell model. We found that PR mainly aggregates into spots in the nucleus and induces significant NLRP3 inflammasome activity. Moreover, mouse NSC-34 motor neuron cells treated with a conditional medium of PR-expressing HMC3 cells (PR-CM) caused cell damage and apoptosis activity. However, R-expressing HMC cells treated with MCC950 (an NLRP3 inhibitor) reversed this result. Furthermore, we identified complement component 1 q subcomponent-binding protein (C1QBP) as one of the interaction partners of PR. The downregulation of C1QBP in HMC3 cells induces NLRP3 inflammasome activity similar to PR expression. Finally, we found that syringin can block the interaction between PR and C1QBP, and effectively reduce the PR-induced NLRP3 inflammasome activity in HMC3 cells. This improves the apoptosis of NSC-34 cells caused by PR-CM. This study is the first to link PR, C1QBP, and NLRP3 inflammasome activity in microglia and develop potential therapeutic strategies for syringin intervention in C9-ALS.

Citing Articles

dipeptides activate the NLRP3 inflammasome.

Rivers-Auty J, Hoyle C, Pointer A, Lawrence C, Pickering-Brown S, Brough D Brain Commun. 2024; 6(5):fcae282.

PMID: 39229486 PMC: 11369816. DOI: 10.1093/braincomms/fcae282.

RNA 5-methylcytosine marks mitochondrial double-stranded RNAs for degradation and cytosolic release.

Kim S, Tan S, Ku J, Widowati T, Ku D, Lee K Mol Cell. 2024; 84(15):2935-2948.e7.

PMID: 39019044 PMC: 11316625. DOI: 10.1016/j.molcel.2024.06.023.

Elevated NLRP3 Inflammasome Activation Is Associated with Motor Neuron Degeneration in ALS.

Cihankaya H, Bader V, Winklhofer K, Vorgerd M, Matschke J, Stahlke S Cells. 2024; 13(12.

PMID: 38920626 PMC: 11202041. DOI: 10.3390/cells13120995.

Molecular clues unveiling spinocerebellar ataxia type-12 pathogenesis.

Kumar M, Sahni S, A V, Kumar D, Kushwah N, Goel D iScience. 2024; 27(5):109768.

PMID: 38711441 PMC: 11070597. DOI: 10.1016/j.isci.2024.109768.

Pectolinarigenin Improves Oxidative Stress and Apoptosis in Mouse NSC-34 Motor Neuron Cell Lines Induced by C9-ALS-Associated Proline-Arginine Dipeptide Repeat Proteins by Enhancing Mitochondrial Fusion Mediated via the SIRT3/OPA1 Axis.

Fu R Antioxidants (Basel). 2023; 12(11).

PMID: 38001861 PMC: 10669908. DOI: 10.3390/antiox12112008.

References

Ghebrehiwet B, Geisbrecht B, Xu X, Savitt A, Peerschke E . The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1). Semin Immunol. 2019; 45:101338. DOI: 10.1016/j.smim.2019.101338. View

Barna J, Dimen D, Puska G, Kovacs D, Csikos V, Olah S . Complement component 1q subcomponent binding protein in the brain of the rat. Sci Rep. 2019; 9(1):4597. PMC: 6418184. DOI: 10.1038/s41598-019-40788-z. View

Noh S, Phorl S, Naskar R, Oeum K, Seo Y, Kim E . p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis. Sci Rep. 2020; 10(1):10618. PMC: 7327069. DOI: 10.1038/s41598-020-67457-w. View

Ding H, Deng Y, Yang R, Wang Q, Jiang W, Han Y . Hypercapnia induces IL-1β overproduction via activation of NLRP3 inflammasome: implication in cognitive impairment in hypoxemic adult rats. J Neuroinflammation. 2018; 15(1):4. PMC: 5755461. DOI: 10.1186/s12974-017-1051-y. View

Zhang N, Zhao L, Su Y, Liu X, Zhang F, Gao Y . Syringin Prevents Aβ-Induced Neurotoxicity in SK-N-SH and SK-N-BE Cells by Modulating miR-124-3p/BID Pathway. Neurochem Res. 2021; 46(3):675-685. DOI: 10.1007/s11064-021-03240-1. View

Deora V, Lee J, Albornoz E, McAlary L, Jagaraj C, Robertson A . The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2019; 68(2):407-421. DOI: 10.1002/glia.23728. View

Lv S, Li X, Wang H . The Role of the Effects of Endoplasmic Reticulum Stress on NLRP3 Inflammasome in Diabetes. Front Cell Dev Biol. 2021; 9:663528. PMC: 8079978. DOI: 10.3389/fcell.2021.663528. View

Yin S, Lopez-Gonzalez R, Kunz R, Gangopadhyay J, Borufka C, Gygi S . Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients. Cell Rep. 2017; 19(11):2244-2256. PMC: 5653973. DOI: 10.1016/j.celrep.2017.05.056. View

Rostalski H, Leskela S, Huber N, Katisko K, Cajanus A, Solje E . Astrocytes and Microglia as Potential Contributors to the Pathogenesis of Repeat Expansion-Associated FTLD and ALS. Front Neurosci. 2019; 13:486. PMC: 6529740. DOI: 10.3389/fnins.2019.00486. View

10.

Wang C, Zhang Q, Xun Z, Yuan L, Li R, Li X . Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer's models. Redox Biol. 2020; 36:101672. PMC: 7452088. DOI: 10.1016/j.redox.2020.101672. View

11.

McCauley M, Baloh R . Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2018; 137(5):715-730. PMC: 6482122. DOI: 10.1007/s00401-018-1933-9. View

12.

Moens T, Niccoli T, Wilson K, Atilano M, Birsa N, Gittings L . C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A. Acta Neuropathol. 2019; 137(3):487-500. PMC: 6514073. DOI: 10.1007/s00401-018-1946-4. View

13.

Reef S, Shifman O, Oren M, Kimchi A . The autophagic inducer smARF interacts with and is stabilized by the mitochondrial p32 protein. Oncogene. 2007; 26(46):6677-83. DOI: 10.1038/sj.onc.1210485. View

14.

Wang Y, Wu H, Han Z, Sheng H, Wu Y, Wang Y . Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke. Phytomedicine. 2022; 99:154034. DOI: 10.1016/j.phymed.2022.154034. View

15.

Goutman S, Hardiman O, Al-Chalabi A, Chio A, Savelieff M, Kiernan M . Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022; 21(5):465-479. PMC: 9513754. DOI: 10.1016/S1474-4422(21)00414-2. View

16.

Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah S, Shi Y . Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014; 84(6):1213-25. PMC: 4632245. DOI: 10.1016/j.neuron.2014.12.010. View

17.

Choi K, Koo B, Yoon B, Jung M, Yun H, Jeon B . Overexpressed p32 localized in the endoplasmic reticulum and mitochondria negatively regulates calcium‑dependent endothelial nitric oxide synthase activit. Mol Med Rep. 2020; 22(3):2395-2403. PMC: 7411372. DOI: 10.3892/mmr.2020.11307. View

18.

Huang Y, Zhou J, Zhang H, Canfran-Duque A, Singh A, Perry R . Brown adipose TRX2 deficiency activates mtDNA-NLRP3 to impair thermogenesis and protect against diet-induced insulin resistance. J Clin Invest. 2022; 132(9). PMC: 9057632. DOI: 10.1172/JCI148852. View

19.

Wong J, Alfatah M, Sin M, Sim H, Verma C, Lane D . A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53. BMC Biol. 2017; 15(1):108. PMC: 5680816. DOI: 10.1186/s12915-017-0446-7. View

20.

Zhang X, Zeng W, Zhang Y, Yu Q, Zeng M, Gan J . Focus on the role of mitochondria in NLRP3 inflammasome activation: A prospective target for the treatment of ischemic stroke (Review). Int J Mol Med. 2022; 49(6). PMC: 9015651. DOI: 10.3892/ijmm.2022.5130. View